NURS 3210 CH 26 PPT
40 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to Lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the primary indication for argatroban, and how is it administered?

Active HIT and percutaneous coronary intervention procedures in patients at risk for HIT, and it is only given IV.

What is the mechanism of action of dabigatran, and what is its approved indication?

Dabigatran is a prodrug that becomes activated in the liver, and it specifically and reversibly binds to both free and clot-bound thrombin. It is approved for prevention of strokes and thrombosis in patients with non-valvular atrial fibrillation.

What is the main difference between enoxaparin and unfractionated heparin, and why is lab monitoring not necessary for enoxaparin?

Enoxaparin has a higher degree of bioavailability and a longer elimination half-life than unfractionated heparin. Lab monitoring is not necessary because of its predictable dose-response and low interpatient variability.

How is heparin typically administered for DVT prophylaxis, and why is aPTT monitoring not necessary in this setting?

<p>Heparin is administered subcutaneously two or three times a day, and aPTT monitoring is not necessary for prophylaxis because the dose is fixed and not adjusted based on lab results.</p> Signup and view all the answers

What is the difference in heparin administration and monitoring between prophylactic and therapeutic uses?

<p>For prophylaxis, heparin is administered subcutaneously two or three times a day, and aPTT monitoring is not necessary. For therapeutic use, heparin is administered as a continuous IV infusion, and aPTT monitoring is necessary to adjust the dose.</p> Signup and view all the answers

What are the potential adverse effects of dabigatran, and how does its dose depend on renal function?

<p>The potential adverse effects of dabigatran include bleeding and GI bleeding. The dose of dabigatran depends on renal function, and the dose should be adjusted in patients with renal impairment.</p> Signup and view all the answers

What is the difference between enoxaparin and unfractionated heparin in terms of their affinity for factor Xa and thrombin?

<p>Enoxaparin has a higher affinity for factor Xa than for thrombin, whereas unfractionated heparin has a higher affinity for thrombin.</p> Signup and view all the answers

What is the mechanism of action of Factor Xa inhibitors in preventing thrombosis?

<p>They inhibit thrombosis by their specific action against factor Xa.</p> Signup and view all the answers

When is coagulation monitoring required for anticoagulant therapy, and what lab test is typically used?

<p>Coagulation monitoring is required for heparin therapy, and the aPTT is typically used to monitor the therapeutic effect.</p> Signup and view all the answers

What is the primary goal of antithrombotic prophylaxis in patients undergoing major orthopedic surgery?

<p>To prevent venous thromboembolism and pulmonary embolism.</p> Signup and view all the answers

What is the difference between unfractionated heparin and low-molecular-weight heparins (LMWHs) in terms of their effects on bleeding times?

<p>Unfractionated heparin requires frequent laboratory monitoring of bleeding times, whereas LMWHs have a more predictable anticoagulant response and do not require frequent monitoring.</p> Signup and view all the answers

What is the mechanism of action of warfarin in preventing clot formation?

<p>Warfarin inhibits the production of vitamin K-dependent clotting factors II, VII, IX, and X, which are necessary for clot formation.</p> Signup and view all the answers

What is the primary advantage of direct oral anticoagulants (DOACs) compared to warfarin?

<p>DOACs have a more predictable anticoagulant response and do not require frequent laboratory monitoring.</p> Signup and view all the answers

What is the primary indication for anticoagulant therapy in patients with atrial fibrillation?

<p>To prevent stroke and systemic embolism.</p> Signup and view all the answers

What is the primary contraindication for anticoagulant therapy?

<p>Any acute bleeding process or high risk for such an occurrence.</p> Signup and view all the answers

What is the primary advantage of factor Xa inhibitors over vitamin K antagonists?

<p>Factor Xa inhibitors have a more rapid onset of action and a shorter half-life, making them more suitable for acute thrombotic events.</p> Signup and view all the answers

What is an essential aspect of patient education for anticoagulant therapy?

<p>Importance of regular laboratory testing</p> Signup and view all the answers

What should patients taking warfarin (Coumadin) be advised to consume consistently?

<p>Foods high in vitamin K</p> Signup and view all the answers

What is a crucial nursing consideration when administering thrombolytic drugs?

<p>Following strict manufacturer's guidelines for preparation and administration</p> Signup and view all the answers

What is a key concern for patients receiving antiplatelet therapy?

<p>Drug-drug interactions</p> Signup and view all the answers

What should the nurse monitor for when converting a patient from IV heparin to oral warfarin (Coumadin) therapy?

<p>INR</p> Signup and view all the answers

Why is overlapping therapy of IV heparin and warfarin necessary?

<p>To ensure continued anticoagulation</p> Signup and view all the answers

What is a sign of abnormal bleeding that the nurse should monitor for in a patient receiving thrombolytic drugs?

<p>Bleeding from gums, mucous membranes, nose, and injection sites</p> Signup and view all the answers

What should the nurse emphasize in patient education for patients taking anticoagulants?

<p>Measures to prevent bruising, bleeding, and tissue injury</p> Signup and view all the answers

What is the specific antidote for dabigatran and what is its purpose?

<p>Idarucizumab (Praxbind) is the specific antidote for dabigatran, and it is used to reverse the anticoagulant effects for emergency surgery or in life-threatening or uncontrolled bleeding.</p> Signup and view all the answers

What is therisk of administering IV vitamin K and how can it be minimized?

<p>The risk of administering IV vitamin K is anaphylaxis, and it can be minimized by diluting it and giving it over 30 minutes.</p> Signup and view all the answers

What is the specific antidote for factor Xa inhibitors and what are the associated risks?

<p>Andexxa (Coagulation Factor Xa [recombinant] Inactivated-zhzo) is the specific antidote for factor Xa inhibitors, such as rivaroxaban and apixaban, and it carries a risk of thromboembolic events, including MI, ischemic stroke, cardiac arrest, and sudden death.</p> Signup and view all the answers

What is the caution when giving vitamin K to a patient taking warfarin?

<p>The caution when giving vitamin K to a patient taking warfarin is that warfarin resistance will occur for up to 7 days.</p> Signup and view all the answers

What are the potential mechanisms of drug interactions with anticoagulants?

<p>The potential mechanisms of drug interactions with anticoagulants include enzyme inhibition of metabolism, displacement of the drug from inactive protein-binding sites, decrease in vitamin K absorption or synthesis by the bacterial flora of the large intestines, and alteration in the platelet count or activity.</p> Signup and view all the answers

What is the crucial consideration when ordering two anticoagulants?

<p>The crucial consideration when ordering two anticoagulants is to always question the order, as it may increase the risk of adverse interactions and bleeding complications.</p> Signup and view all the answers

What is the treatment for severe bleeding due to warfarin overdose?

<p>The treatment for severe bleeding due to warfarin overdose includes transfusions of human plasma or clotting factor concentrates, and in life-threatening bleeding, Kcentra and Profiline may be used.</p> Signup and view all the answers

What is the specific antidote for life-threatening bleeding due to warfarin?

<p>The specific antidote for life-threatening bleeding due to warfarin is Kcentra and Profiline.</p> Signup and view all the answers

What is the primary mechanism of action of Rivaroxaban (Xarelto)?

<p>Inhibiting factor Xa</p> Signup and view all the answers

What is the therapeutic INR range for patients with atrial fibrillation on warfarin therapy?

<p>2-3.5</p> Signup and view all the answers

Why is heparin often used in combination with warfarin therapy?

<p>To provide anticoagulation until therapeutic levels of warfarin are reached</p> Signup and view all the answers

What genetic factors can affect warfarin dosing?

<p>Variations in CYP2CP and VKORC1 genes</p> Signup and view all the answers

What is the primary indication for Rivaroxaban (Xarelto) in orthopedic surgery?

<p>Post-operative thromboprophylaxis</p> Signup and view all the answers

What is the potential consequence of not monitoring the PT/INR in patients on warfarin therapy?

<p>Bleeding or thrombosis</p> Signup and view all the answers

What is the mechanism of action of warfarin?

<p>Inhibition of vitamin K-dependent clotting factors</p> Signup and view all the answers

What is the primary advantage of factor Xa inhibitors over warfarin?

<p>Fixed dosing and no need for INR monitoring</p> Signup and view all the answers

Study Notes

Anticoagulants and Antiplatelet Drugs

Treatment of Toxic Effects of Warfarin

  • Caution: Vitamin K administration can cause warfarin resistance for up to 7 days
  • Severe bleeding: treat with transfusions of human plasma or clotting factor concentrates
  • Life-threatening bleeding: use Kcentra and Profiline
  • IV vitamin K administration: risk of anaphylaxis, minimize by diluting and giving over 30 minutes

Idarucizumab (Praxbind)

  • Specific antidote for dabigatran
  • Reverses anticoagulant effects of dabigatran for emergency surgery or life-threatening/uncontrolled bleeding

Andexxa (Coagulation Factor Xa [recombinant] Inactivated-zhzo)

  • Specific antidote for factor Xa inhibitors
  • Used for life-threatening or uncontrolled bleeding
  • Black Box Warning: thromboembolic events, MI, ischemic stroke, cardiac arrest, sudden death

Drug Interactions: Anticoagulants

  • Enzyme inhibition of metabolism
  • Displacement of drug from inactive protein-binding sites
  • Decrease in vitamin K absorption or synthesis by bacterial flora of the large intestine
  • Alteration in platelet count or activity

Argatroban

  • Synthetic direct thrombin inhibitor
  • Used for active HIT and percutaneous coronary intervention procedures in patients at risk for HIT
  • Only given IV

Dabigatran (Pradaxa)

  • First oral direct thrombin inhibitor approved for prevention of strokes and thrombosis in patients with non-valvular atrial fibrillation
  • Prodrug that becomes activated in the liver
  • Specifically and reversibly binds to both free and clot-bound thrombin
  • Dose dependent on renal function
  • Adverse effects: bleeding, GI bleeding
  • No coagulation monitoring required

Enoxaparin (Lovenox)

  • Prototypical LMWH
  • Greater affinity for factor Xa than for factor IIa
  • Higher degree of bioavailability and longer elimination half-life
  • No lab monitoring required
  • Injectable form
  • Used for prophylaxis and treatment
  • Pre-filled syringes, do not expel air bubble

Heparin

  • Natural anticoagulant obtained from lungs or intestinal mucosa of pigs
  • 10 to 40,000 units/mL
  • DVT prophylaxis: 5000 units subcutaneously two or three times a day, no need to monitor aPTT
  • Therapeutic use: continuous IV infusion, monitor aPTT every 6 hours until therapeutic effects seen
  • Numerous factors can affect action

Coagulation Modifier Drugs

  • Anticoagulants: inhibit action or formation of clotting factors, prevent clot formation
  • Antiplatelet drugs: inhibit platelet aggregation, prevent platelet plugs
  • Hemorheologic drugs: alter platelet function without preventing platelet activity
  • Thrombolytic drugs: lyse existing clots
  • Antifibrinolytic or hemostatic drugs: promote blood coagulation

Anticoagulants

  • Also known as antithrombotic drugs
  • No direct effect on already formed blood clots
  • Prevent intravascular thrombosis by decreasing blood coagulability
  • Used prophylactically to prevent clot formation, thrombus, and embolus

Embolus

  • Thromboembolic events
  • Myocardial infarction (MI): embolus lodges in coronary artery
  • Stroke: embolus obstructs brain vessel
  • Pulmonary emboli: embolus in pulmonary circulation
  • Deep vein thrombosis (DVT): embolus goes to vein in leg

Anticoagulants: Heparins

  • Action: inhibit clotting factors IIa and Xa
  • Unfractionated heparin: "heparin"
  • Low-molecular-weight heparins (LMWHs): enoxaparin (Lovenox) and dalteparin (Fragmin)

Anticoagulants: Coumarins

  • Action: inhibit vitamin K-dependent clotting factors II, VII, IX, and X
  • Warfarin (Coumadin)

Anticoagulants: Factor Xa Inhibitors

  • Fondaparinux (Arixtra)
  • Direct oral anticoagulants: rivaroxaban (Xarelto), apixaban (Eliquis), edoxaban (Savaysa), betrixaban (Bevyxxa)
  • Inhibit thrombosis by specific action against factor Xa

Anticoagulants: Direct Thrombin Inhibitors

  • Action: inhibit thrombin (factor IIa)
  • Natural: human antithrombin III (Thrombate)
  • Synthetic: lepirudin (Refludan), argatroban (Argatroban), bivalirudin (Angiomax), dabigatran (Pradaxa) (oral)

Anticoagulants: Indications

  • Used to prevent clot formation in settings where clot formation is likely
  • MI, unstable angina, atrial fibrillation, indwelling devices, major orthopedic surgery

Anticoagulants: Contraindications

  • Drug allergy
  • Any acute bleeding process or high risk for such occurrence

Anticoagulants: Patient Education

  • Importance of regular laboratory testing
  • Signs of abnormal bleeding
  • Measures to prevent bruising, bleeding, and tissue injury
  • Wearing a medical alert bracelet
  • Consistent intake of foods high in vitamin K
  • Consulting physician before taking other drugs or OTC products, including herbals

Antiplatelet and Thrombolytic Drugs: Nursing Implications

  • Concerns and teaching tips same as for anticoagulants
  • Drug-drug interactions
  • Adverse reactions to report
  • Monitoring for abnormal bleeding

Studying That Suits You

Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

Quiz Team

Related Documents

Anticoagulants- Chapter 26.pptx

More Like This

Use Quizgecko on...
Browser
Open
Browser
Browser